Shares in the robotics concept sector exhibited significant strength. At the time of writing, ESTUN (02715) surged 20.35% to HK$23.06. LAIFUAL (03952) gained 13.08% to HK$73.40. MicroPort MedBot - B (02252) advanced 13.39% to HK$26.42. ZHAOWEI (02692) rose 11.8% to HK$54.40. JOHNSON ELEC H (00179) climbed 10.18% to HK$22.72. SANHUA (02050) increased by 8.37% to HK$29.78.

Key Catalysts Driving the Rally

On July 2nd, the China Securities Regulatory Commission (CSRC) announced its approval for Unitree Technology Co., Ltd.'s registration for an initial public offering on the STAR Market. Industry observers note that Unitree's IPO launch signifies the imminent arrival of the A-share market's first "embodied AI" stock, which could systematically elevate the valuation benchmark for the domestic robotics industry chain.

Industry Momentum Builds

The robotics sector has recently seen a cluster of positive developments. Earlier, UBTECH's ultra-bionic humanoid robot garnered significant attention, with pre-orders for its U1 model exceeding 13,000 units. Internationally, Nvidia is expanding its robotics research and development teams across Beijing, Shanghai, and Shenzhen. Meanwhile, Tesla's humanoid robot, Optimus, is moving closer to mass production.

Production and Market Outlook

A Nomura research report highlighted that Tesla has raised the annualized production target for its Optimus Gen 3 line in Fremont from 50,000 units to approximately 70,000 units. The company also plans to add around 70,000 units of capacity in Austin by 2028, with a long-term combined capacity target of 1.5 million units. Huaxin Securities expressed the view that the overall positioning of the robotics sector is currently moderate. With Tesla's supply chain catalysts progressing and the Optimus v3 expected to be released mid-year, the firm maintains a positive outlook on the sector's sustained performance.